文献速递冠心病

德国多中心COGIA研究:儿童及青少年Brugada综合征的诊断挑战与临床结局

Brugada Syndrome in the Pediatric Population: Diagnostic Challenges and Clinical Outcome—Results of the German Multicenter Study COGIA
RSS 订阅 · Journal of Cardiovascular Electrophysiology · 2026-08-30

德国多中心COGIA研究纳入12个中心76例疑似Brugada综合征(BrS)的儿童及青少年患者,评估当前诊断标准的适用性与临床结局。39例(51.3%)符合ESC诊断标准,其中34例(44.7%)符合上海评分标准。4例(5.3%)发生主要心律失常事件,且均见于符合诊断标准者;首次就诊时有症状是主要心律失常事件的独立危险因素(HR=11.3,P=0.04)。

要点

  • 儿科疑似BrS中仅约半数符合ESC诊断标准,诊断确立仍具挑战。
  • 首次就诊时有症状是主要心律失常事件的独立危险因素(HR=11.3)。
  • 主要心律失常事件均发生于符合诊断标准的患者中。

核心结论

  • 儿童及青少年疑似Brugada综合征的诊断确立仍具有挑战性。
  • 疑似BrS儿科患者中主要心律失常事件发生率为5.3%,且均见于符合诊断标准者。
  • 首次就诊时有症状增加主要心律失常事件风险。

研究设计与样本

  • 德国多中心研究COGIA,纳入12个德国三级医疗中心的76例疑似BrS儿科患者。
  • 主要结局为主要心律失常事件,次要结局为症状、药物治疗和器械植入。
  • 主要心律失常事件定义为心脏性猝死、心脏骤停幸存和恰当的植入式心律转复除颤器治疗。

主要发现

  • 76例中39例(51.3%)符合ESC指南的BrS诊断标准,34例(44.7%)符合上海评分标准。
  • 66例接受基因检测的患儿中31例(47.0%)检出(可能)致病性SCN5A变异。
  • 临床诊断者中SCN5A变异检出率为14/30(46.7%),无临床诊断者中为17/36(47.2%)。
  • 25例接受阿义马林激发试验者中19例(76.0%)阳性。

关键数值与推荐

  • 符合ESC诊断标准者占51.3%(39/76),符合上海评分标准者占44.7%(34/76)。
  • 阿义马林激发试验阳性率为76.0%(19/25)。
  • 全队列中首次就诊时有症状对主要心律失常事件的HR为11.3,P=0.04。

临床怎么用

  • 对疑似BrS的儿科患者应结合ESC诊断标准和上海评分进行综合评估。
  • 首次就诊时有症状的疑似BrS儿童需密切随访并加强心律失常事件监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The study examines 76 patients of the German multicenter study COGIA with suspected BrS in 12 centers in Germany. Thirty-nine patients met the current ESC diagnostic criteria, 34 of whom met the Shanghai Score criteria. Four major arrhythmic events (ACA, SCD, appropriate ICD shock) occurred in the cohort (5.3%), all in the group of patients fulfilling current diagnostic criteria. Risk factor analysis showed an increased risk of MAEs in patients with symptoms at the initial examination. In summary, diagnosis in children and adolescents with BrS remains challenging. ABSTRACT Introduction Diagnosis and treatment of children and adolescents with suspected Brugada syndrome (BrS) is challenging. Aim of the study was to evaluate the applicability of current diagnostic criteria for pediatric patients with suspected BrS in the German multicenter study COGIA and to assess clinical outcome. Methods Data analysis of 76 pediatric patients from 12 German tertiary care centers. Primary outcome was defined by the occurrence of a major arrhythmic event (MAE), secondary outcome by symptoms, pharmacotherapy and implantation of devices. MAE was defined as sudden cardiac death (SCD), aborted cardiac arrest (ACA) and appropriate implantable cardioverter-defibrillator (ICD) therapy. Results Criteria for BrS diagnosis were fulfilled in 39/76 pediatric patients (51.3%) according to ESC Guidelines, including 34 patients (44.7%) according to Shanghai Score. Genetic testing identified a (likely) pathogenic SCN5A variant in 31/66 tested children (47.0%) (14/30 with clinical diagnosis (46.7%) and 17/36 without clinical diagnosis (47.2%)). Twenty-four patients (31.6%) showed a spontaneous type 1 ECG pattern, in 6 patients (7.9%) it was induced by fever. Ajmaline challenge was positive in 19/25 patients (76.0%). Syncope occurred in 15 patients (19.7%) and an ICD was implanted in 7 pediatric patients (9.2%). Four patients (5.3%) experienced a MAE (ACA), all of them fulfilling diagnostic criteria. “Symptoms at first consultation” was identified as an independent risk factor for MAE in the whole cohort (HR = 11.3, p = 0.04). Conclusion Establishing the diagnosis of BrS remains challenging in the pediatric cohort. MAE occurred in 5.3% of patients with suspected BrS. Symptoms at first consultation increased risk for MAE. Clinical Trial Registration: The study is registered at the German Clinical Trial Register (DRKS) of the Federal Institute for Drugs and Medical Devices (BfArM), DRKS-ID DRKS

来源:Journal of Cardiovascular Electrophysiology,查看原文。版权归原作者所有。

引用

  1. Journal of Cardiovascular Electrophysiology:Brugada Syndrome in the Pediatric Population: Diagnostic Challenges and Clinical Outcome—Results of the German Multicenter Study COGIA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。